Vetoquinol SA

Paris Stock Exchange VETO.PA

Vetoquinol SA Price to Book Ratio (P/B) on January 14, 2025: 1.53

Vetoquinol SA Price to Book Ratio (P/B) is 1.53 on January 14, 2025, a -35.23% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Vetoquinol SA 52-week high Price to Book Ratio (P/B) is 2.44 on January 24, 2024, which is 59.66% above the current Price to Book Ratio (P/B).
Vetoquinol SA 52-week low Price to Book Ratio (P/B) is 1.53 on January 14, 2025, which is 0.00% below the current Price to Book Ratio (P/B).
Vetoquinol SA average Price to Book Ratio (P/B) for the last 52 weeks is 2.07.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Paris Stock Exchange: VETO.PA

Vetoquinol SA

CEO	Mr. Alain Masson
IPO Date	Nov. 17, 2006
Location	France
Headquarters	Magny-Vernois
Employees	2,519
Sector	Health Care
Industries Pharmaceuticals

Description

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, and dogs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.

Key trends

Past 5 years